Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva, Switzerland TB prevention, care and control, 2010-2015: Framing global and WHO strategic.

Slides:

Advertisements

Similar presentations

Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.

Advertisements

Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,

The relative importance of DOTS. DOTS Strategy 2005 Prevention starts with cure : New STOP TB Strategy -Development of new medical technologies.

From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.

Renewing Health Canada’s strategy against TB for First Nations on-reserve Provincial Primary Care Tuberculosis Education Day October 28, 2011 Presented.

Breaking Silos: TB and Poverty Bobby Ramakant, Rachael Thomson STOP TB Partnership TB and Poverty Subgroup.

REPORT HIGHLIGHTS “Children should be the first to benefit from our successes in defeating HIV, and the last to suffer from our failures.” Anthony Lake,

End TB strategy target setting

Thailand’s HIV and AIDS STRATEGY

Almost 14 years ago all countries endorsed a set of 8 Millennium Development Goals (or MDGs). 3 of those 8 Goals focus on health – that being child mortality,

Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.

Technical Advisory Group meeting, WHO/WPRO

Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.

1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.

African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.

THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.

Framework and Standards for Effective TB Control Module 3 – March 2010

DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.

COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.

WHO Technical Briefing Seminar on Essential Medicines & Health Products, October 2013 Noncommunicable Diseases –Action Plan Dr Shanthi Mendis Director,

WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.

The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.

TB and Poverty in The Global Plan to Stop TB Valerie Diaz, Sarah England, Knut Lönnroth, Giorgio Roscigno Stop TB Partnership Stop TB Department,

Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?

African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.

Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.

R&D for TB: Updates & Opportunities for the Private Sector Christian Lienhardt Senior Scientific Advisor, Stop TB Partnership WHO, Geneva GBC Conference.

1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.

Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.

End TB Strategy HCW with cough since January. Seen at government clinic thrice with no sputum/CXR. Diagnosed TB in May only.

1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.

Proposed Post-2015 Global Tuberculosis Strategy and Targets Dr Mario Raviglione Director, Global TB Programme World Health Organization, Geneva, Switzerland.

Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.

Leprosy – cross-cutting issues with NTDs Doug Soutar ILEP General Secretary WORKING TOGETHER FOR A WORLD WITHOUT LEPROSY.

Dana Farcasanu Foundation Center for Health Policies and Services

Colleen Daniels Stop TB Department World Health Organisation TB, HIV and Drug Use The overview.

Moving ahead with the Stop TB Strategy: where are we today? Dr Mario Raviglione Director, WHO Stop TB Department Joint Meeting of Core Teams and High Burden.

Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.

Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.

TB HIV Research Perspectives of The Union Riitta Dlodlo, MD, MPH HIV Programme Coordinator The International Union Against Tuberculosis and Lung Disease.

1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.

The Bank’s Regional HIV/AIDS Strategies An Overview.

CENTENNIAL DECLARATION on the role of NGOs in Tuberculosis Control Dr. Maarten van Cleeff, Project Director TBCTA Keeping the Pledge Delhi, March 2003.

Global Tuberculosis Control 2007 Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?

Tuberculosis demand forecast Brussels, 10 April 2013 Dr Mario Raviglione Director, Stop TB Department World Health Organization, Geneva, Switzerland.

2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.

National TB Infection Control Seminar S’celo S. Dlamini Director: Research, Information, Monitoring, Evaluation & Surveillance 12 th of August 2015 Integrating.

TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.

TB and the right to health Nelson Otwoma National Coordinator- NEPHAK.

Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?

Thailand’s HIV and AIDS STRATEGY

Maintaining Visibility 2009

GARD/NCD Action Plan & 2011 UN Summit on NCDs

Stop TB Partnership Secretariat (TBP)

Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.

Sunday, 22 July, 07:30-20:00 Room Elicium 1, RAI Amsterdam

Stop TB Partnership Secretariat (TBP) M. Espinal, Executive Secretary

Convegno, Stop TB Italia – Milano,

Key issues in DOTS implementation

ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS

TB Strategy & Health Systems (TBS) TB Monitoring & Evaluation (TME)

Vietnam Investment and Finance for TB

ACSM in 2010: Overview of SG Achievements

5th DEWG meeting Conclusions

Geneva, Switzerland June 2002

The STOP TB Strategy – 2009 VISION: A TB-free world

A Time of Commitments and Actions to accelerate action to End TB

Background & rational DEWG meeting 2009

Monitoring and Evaluation: A Review of Terms

Strategic framework for TB/HIV

Presentation transcript:

Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva, Switzerland TB prevention, care and control, : Framing global and WHO strategic priorities Stop TB Symposium "Addressing poverty through quality TB control and research" 3 December 2009, Cancun, Mexico Stop TB Symposium "Addressing poverty through quality TB control and research" 3 December 2009, Cancun, Mexico

Achievements by DOTS/Stop TB Strategy: million cases treated 2.36 million cured 3.Up to 8 million deaths averted compared to non-DOTS treatment 4.Case fatality rate halved (from 7.6% to 4%) 5.Treatment success rate at its highest ever (87% in 2007)

Innovative action needed in 4 spheres: "Moving beyond the TB box" TB control sphere Development sphere Research sphere Health system sphere This is not enough

Global & WHO strategic priorities TB sphere Supporting NTPs in coherent pursuit of Stop TB Strategy Supporting all partners in TB and MDR- TB prevention, care and control; TB advocacy; TB monitoring & evaluation Emphasizing early and active case detection to stop transmission Health system sphere Eliminating financial barriers Overcoming human resources crisis Laboratory strengthening Drug quality and rational use TB/HIV service integration & PAL Infection control Improving governance, management and responsiveness Development sphere Social protection; housing & urban planning; nutrition/food security; migration; labour Refugees; crises response Human Rights agenda Poverty reduction strategies Research sphere Facilitate TB Research Movement Advocate for growth in basic research, R&D and operational research